BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 36412562)

  • 21. Genomic profiling of esophageal squamous cell carcinoma (ESCC)-Basis for precision medicine.
    Yang JW; Choi YL
    Pathol Res Pract; 2017 Jul; 213(7):836-841. PubMed ID: 28554745
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comprehensive genomic profiling of head and neck squamous cell carcinoma reveals FGFR1 amplifications and tumour genomic alterations burden as prognostic biomarkers of survival.
    Dubot C; Bernard V; Sablin MP; Vacher S; Chemlali W; Schnitzler A; Pierron G; Ait Rais K; Bessoltane N; Jeannot E; Klijanienko J; Mariani O; Jouffroy T; Calugaru V; Hoffmann C; Lesnik M; Badois N; Berger F; Le Tourneau C; Kamal M; Bieche I
    Eur J Cancer; 2018 Mar; 91():47-55. PubMed ID: 29331751
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elevated Preoperative NMPR Predicts an Unfavorable Chance of Survival in Resectable Esophageal Squamous Cell Carcinoma.
    Peng MY; Zuo ZG; Cao FJ; Yu YD; Cai XJ; Wan GX
    Medicina (Kaunas); 2022 Dec; 58(12):. PubMed ID: 36557010
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The correlation between XIAP gene polymorphisms and esophageal squamous cell carcinoma susceptibility and prognosis in a Chinese population.
    Peng H; Wang LG; Wang XZ; Liu AJ
    Pathol Res Pract; 2017 Dec; 213(12):1482-1488. PubMed ID: 29037837
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Whole-Genome Sequencing Reveals Diverse Models of Structural Variations in Esophageal Squamous Cell Carcinoma.
    Cheng C; Zhou Y; Li H; Xiong T; Li S; Bi Y; Kong P; Wang F; Cui H; Li Y; Fang X; Yan T; Li Y; Wang J; Yang B; Zhang L; Jia Z; Song B; Hu X; Yang J; Qiu H; Zhang G; Liu J; Xu E; Shi R; Zhang Y; Liu H; He C; Zhao Z; Qian Y; Rong R; Han Z; Zhang Y; Luo W; Wang J; Peng S; Yang X; Li X; Li L; Fang H; Liu X; Ma L; Chen Y; Guo S; Chen X; Xi Y; Li G; Liang J; Yang X; Guo J; Jia J; Li Q; Cheng X; Zhan Q; Cui Y
    Am J Hum Genet; 2016 Feb; 98(2):256-74. PubMed ID: 26833333
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A genetic variant in CDKN2A/2B locus was associated with poor prognosis in patients with esophageal squamous cell carcinoma.
    Ghobadi N; Mehramiz M; ShahidSales S; Rezaei Brojerdi A; Anvari K; Khazaei M; Rezayi M; Sadegh Khorrami M; Joudi-Mashhad M; Ramshini H; Ahmadi-Simab S; Moradi A; Hassanian SM; Ghayour-Mobarhan M; Boroushaki MT; Ferns GA; Avan A
    J Cell Physiol; 2019 Apr; 234(4):5070-5076. PubMed ID: 30238987
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metformin-Induced Heat Shock Protein Family A Member 6 Is a Promising Biomarker of Esophageal Squamous Cell Carcinoma.
    Sekino N; Kano M; Kobayashi S; Murakami K; Sakata H; Toyozumi T; Endo S; Matsumoto Y; Suito H; Takahashi M; Otsuka R; Yokoyama M; Shiraishi T; Okada K; Kamata T; Ryuzaki T; Hirasawa S; Kinoshita K; Sasaki T; Iida K; Komatsu A; Matsubara H
    Oncology; 2022; 100(5):267-277. PubMed ID: 35134807
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinicopathological and genomic features of superficial esophageal squamous cell carcinomas in nondrinker, nonsmoker females.
    Fukuhara M; Urabe Y; Nakahara H; Ishikawa A; Ishibashi K; Konishi H; Mizuno J; Tanaka H; Tsuboi A; Yamashita K; Hiyama Y; Takigawa H; Kotachi T; Yuge R; Hayes CN; Oka S
    Cancer Med; 2024 Feb; 13(4):e7078. PubMed ID: 38457229
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PIK3CA amplification is associated with poor prognosis among patients with curatively resected esophageal squamous cell carcinoma.
    Kim HS; Lee SE; Bae YS; Kim DJ; Lee CG; Hur J; Chung H; Park JC; Shin SK; Lee SK; Lee YC; Kim HR; Shim YM; Jewell SS; Kim H; Choi YL; Cho BC
    Oncotarget; 2016 May; 7(21):30691-701. PubMed ID: 27095573
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LINE-1 hypomethylation, DNA copy number alterations, and CDK6 amplification in esophageal squamous cell carcinoma.
    Baba Y; Watanabe M; Murata A; Shigaki H; Miyake K; Ishimoto T; Iwatsuki M; Iwagami S; Yoshida N; Oki E; Sakamaki K; Nakao M; Baba H
    Clin Cancer Res; 2014 Mar; 20(5):1114-24. PubMed ID: 24423610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Copine 5 expression predicts prognosis following curative resection of esophageal squamous cell carcinoma.
    Umeda S; Kanda M; Koike M; Tanaka H; Miwa T; Tanaka C; Kobayashi D; Suenaga M; Hayashi M; Yamada S; Nakayama G; Kodera Y
    Oncol Rep; 2018 Dec; 40(6):3772-3780. PubMed ID: 30272363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genome-wide copy number variation analysis identified ANO1 as a novel oncogene and prognostic biomarker in esophageal squamous cell cancer.
    Yu Y; Cao J; Wu W; Zhu Q; Tang Y; Zhu C; Dai J; Li Z; Wang J; Xue L; Zhen F; Liu J; Huang C; Zhao F; Zhou Y; Wen W; Pan X; Wei H; Zhu Y; He Y; Que J; Wang W; Luo J; Xu J; Chen L
    Carcinogenesis; 2019 Oct; 40(10):1198-1208. PubMed ID: 31050728
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The prognostic role of FZD6 in esophageal squamous cell carcinoma patients.
    Zhang J; Wang JL; Zhang CY; Ma YF; Zhao R; Wang YY
    Clin Transl Oncol; 2020 Jul; 22(7):1172-1179. PubMed ID: 31748958
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Somatic CDKN2A copy number variations are associated with the prognosis of esophageal squamous cell dysplasia.
    Fan Z; Zhou J; Tian Y; Qin Y; Liu Z; Gu L; Dawsey SM; Wei W; Deng D
    Chin Med J (Engl); 2024 Apr; 137(8):980-989. PubMed ID: 38445358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
    Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
    Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prognostic influence of preoperative Nutritional Risk Screening -2002 (NRS-2002) score for patients with thoracic esophageal squamous cell carcinoma receiving surgery].
    Sun HJ; Guo XW; Ji SJ; Zhou SB; Gu L
    Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):917-921. PubMed ID: 30605983
    [No Abstract]   [Full Text] [Related]  

  • 37. Low mitochondrial DNA copy number induces chemotherapy resistance via epithelial-mesenchymal transition by DNA methylation in esophageal squamous cancer cells.
    Kubo Y; Tanaka K; Masuike Y; Takahashi T; Yamashita K; Makino T; Saito T; Yamamoto K; Tsujimoto T; Harino T; Kurokawa Y; Yamasaki M; Nakajima K; Eguchi H; Doki Y
    J Transl Med; 2022 Aug; 20(1):383. PubMed ID: 36038893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Consistent and differential genetic aberrations between esophageal dysplasia and squamous cell carcinoma detected by array comparative genomic hybridization.
    Shi ZZ; Shang L; Jiang YY; Hao JJ; Zhang Y; Zhang TT; Lin DC; Liu SG; Wang BS; Gong T; Zhan QM; Wang MR
    Clin Cancer Res; 2013 Nov; 19(21):5867-78. PubMed ID: 24009147
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of preoperative muscle-adipose index measured by computed tomography with survival in patients with esophageal squamous cell carcinoma.
    Qian D; Shen P; Zhu J; Ji S; Kong Y
    World J Surg Oncol; 2024 Feb; 22(1):61. PubMed ID: 38383431
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of CDK6 amplification in esophageal squamous cell carcinoma.
    Liu K; Lu H; Jiang D; Guan Y; Xu H; Sun Q; Jiang Q; Zheng J; Chen H; Zhang F; Luo R; Huang Y; Xu J; Hou Y
    Cancer Treat Res Commun; 2023; 35():100698. PubMed ID: 37023643
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.